CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Medpace Holdings Inc - MEDP CFD

346.00
0.33%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.82
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 347.27
Open 343.1
1-Year Change 16.09%
Day's Range 343.1 - 347.52
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 21, 2025 347.27 9.84 2.92% 337.43 349.41 337.43
Jan 17, 2025 337.21 9.26 2.82% 327.95 343.20 327.95
Jan 16, 2025 336.08 2.50 0.75% 333.58 339.43 330.70
Jan 15, 2025 334.97 0.02 0.01% 334.95 337.63 329.39
Jan 14, 2025 330.54 -9.41 -2.77% 339.95 344.43 327.02
Jan 13, 2025 351.96 1.59 0.45% 350.37 352.53 346.52
Jan 10, 2025 350.42 0.52 0.15% 349.90 358.68 347.27
Jan 8, 2025 353.78 10.83 3.16% 342.95 357.47 340.95
Jan 7, 2025 346.74 4.56 1.33% 342.18 348.31 342.13
Jan 6, 2025 341.50 1.65 0.49% 339.85 346.57 339.85
Jan 3, 2025 339.18 4.23 1.26% 334.95 341.65 330.94
Jan 2, 2025 334.46 -0.31 -0.09% 334.77 340.04 332.95
Dec 31, 2024 332.16 -1.31 -0.39% 333.47 337.41 332.11
Dec 30, 2024 333.17 -1.88 -0.56% 335.05 338.34 329.78
Dec 27, 2024 341.02 1.07 0.31% 339.95 343.29 338.51
Dec 26, 2024 342.66 4.21 1.24% 338.45 343.55 337.95
Dec 24, 2024 342.02 5.02 1.49% 337.00 342.28 334.95
Dec 23, 2024 338.82 1.57 0.47% 337.25 340.17 335.00
Dec 20, 2024 337.36 4.16 1.25% 333.20 342.03 333.19
Dec 19, 2024 335.09 3.19 0.96% 331.90 337.74 327.13

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Medpace Holdings Company profile

About Medpace Holdings Inc

Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. It also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Medpace Holdings Inc revenues increased 23% to $1.14B. Net income applicable to common stockholders increased 25% to $181.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Amortization decrease of 35% to $5.1M (expense), Stock-based Compensation in SGA decrease of 15% to $5.1M (expense).

Industry: Biotechnology & Medical Research (NEC)

5375 Medpace Way
CINCINNATI
OHIO 45227-1543
US

People also watch

XRP/USD

3.16 Price
-0.980% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01578

BTC/USD

103,986.50 Price
-2.790% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Gold

2,757.75 Price
+0.460% 1D Chg, %
Long position overnight fee 0.0110%
Short position overnight fee -0.0193%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,891.00 Price
+1.090% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 680,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading